- Home
- ANL vs ASPI Comparison
ANL vs ASPI Comparison
Compare ANL & ASPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANL | ASPI |
|---|---|---|
| Founded | 2004 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Major Chemicals |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 703.3M | 637.1M |
| IPO Year | 2022 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ANL | ASPI |
|---|---|---|
| Price | $11.72 | $5.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $20.00 | $12.00 |
| AVG Volume (30 Days) | 333.5K | ★ 3.7M |
| Earning Date | 04-10-2026 | 04-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $23,849,000.00 |
| Revenue This Year | $36.02 | $68.41 |
| Revenue Next Year | N/A | $126.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 475.48 |
| 52 Week Low | $0.88 | $3.92 |
| 52 Week High | $17.25 | $14.49 |
Technical Indicators
Market Signals| Indicator | ANL | ASPI |
|---|---|---|
| Relative Strength Index (RSI) | 43.71 | 48.23 |
| Support Level | $6.92 | $5.13 |
| Resistance Level | $12.09 | $5.88 |
| Average True Range (ATR) | 1.51 | 0.42 |
| MACD | -0.51 | -0.07 |
| Stochastic Oscillator | 20.81 | 25.81 |
Price Performance
Historical ComparisonAbout ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.
About ASPI ASP Isotopes Inc.
ASP Isotopes Inc is a materials company focused on producing and commercializing enriched isotopes for the nuclear medicine, healthcare, green energy, and quantum computing industries. Using proprietary technology-the Aerodynamic Separation Process (ASP)-the company enriches isotopes in South Africa, targeting high-value, low-volume markets to reduce reliance on foreign supply chains. Geographically, the company operates in South Africa, Hong Kong and United States generating key revenue from the Hong Kong region.